异基因造血干细胞移植中非血缘供者KIR2DL1、KIR3DL1免疫重建规律的研究
目的在非血缘供者为杀伤细胞免疫球蛋白样受体（ⅪR）．AA基因型的异基因造血干细胞移植（allo．HSCT）中研究KIR2DLl、KIR3DLl的免疫重建规律。方法采用序列特异性引物PCR、流式细胞术和实时荧光定量PCR法，对75对供受者进行KIR基因分型，确定供者均为KIR．AA基因型，并动态检测移植当天及移植后不同时间澎植后0．5个月～〈1．5个月（1个月）、移植后1．5个月～〈2．5个月（2个月）、移植后2．5个月～〈3．5个月（3个月）、移植后3．5个月～〈6．5个月（3-6个月）、移植后6．5个月～〈9．5个月（6-9个月）、移植后9．5个月〈12．5个月（9～12个月）]KIR2DL...
Saved in:
| Published in | 中华血液学杂志 Vol. 38; no. 8; pp. 667 - 672 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | Chinese |
| Published |
215006 苏州大学附属第一医院、江苏省血液研究所
2017
临床检测中心 |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0253-2727 |
| DOI | 10.3760/cma.j.issn.0253-2727.2017.08.004 |
Cover
| Abstract | 目的在非血缘供者为杀伤细胞免疫球蛋白样受体（ⅪR）．AA基因型的异基因造血干细胞移植（allo．HSCT）中研究KIR2DLl、KIR3DLl的免疫重建规律。方法采用序列特异性引物PCR、流式细胞术和实时荧光定量PCR法，对75对供受者进行KIR基因分型，确定供者均为KIR．AA基因型，并动态检测移植当天及移植后不同时间澎植后0．5个月～〈1．5个月（1个月）、移植后1．5个月～〈2．5个月（2个月）、移植后2．5个月～〈3．5个月（3个月）、移植后3．5个月～〈6．5个月（3-6个月）、移植后6．5个月～〈9．5个月（6-9个月）、移植后9．5个月〈12．5个月（9～12个月）]KIR2DLl、KIR3DLl膜蛋白和mRNA的表达水平。结果KIR2DL膜蛋白中位表达水平：非血缘供者移植当天为21．60％，受者在1、2、3、3-6个月时表达水平分别为7．40％、12．00％、16．92％、17．64％；KIR2DLl的mRNA中位表达水平：非血缘供者移植当天为265．14／10。ABL拷贝数，受者移植后1、2、3、3-6、6-9、9-12个月时表达水平分别为332．17、438．31、723．25、414．17、187．60及234．67／10。ABL拷贝数。KIR2DLl的mRNA和膜蛋白表达水平在移植后各个时间点均逐渐升高，且在3个月后达到最高，但mRNA表达水平升高早于膜蛋白。（2）KIR3DLl膜蛋白中位表达水平：非血缘供者移植当天为18．56％，受者在移植后1、2、3、3-6个月时表达水平分别为23．83％、22．57％、23．02％、21．60％；KIR3DLlmRNA中位表达水平：非血缘供者移植当天为572．29／10。ABL拷贝数，受者移植后1、2、3、3-6、6-9、9-12个月时表达水平分别为1233．74、1140．42、876．73、1057．07、739．02、514．43／10。ABL拷贝数。KIR3DLl的mRNA和膜蛋白在移植后1个月的表达水平均已超过了非血缘供者，并在移植后各个时间点均稳定高表达，且mRNA与膜蛋白表达水平同步升高。结论KIR2DLl和KIR3DLl基因移植后的免疫重建规律性不同，为在移植后选择最佳时间点定量检测KIR2DLl、KIR3DLl表达水平提供了实验依据。 |
|---|---|
| AbstractList | 目的在非血缘供者为杀伤细胞免疫球蛋白样受体（ⅪR）．AA基因型的异基因造血干细胞移植（allo．HSCT）中研究KIR2DLl、KIR3DLl的免疫重建规律。方法采用序列特异性引物PCR、流式细胞术和实时荧光定量PCR法，对75对供受者进行KIR基因分型，确定供者均为KIR．AA基因型，并动态检测移植当天及移植后不同时间澎植后0．5个月～〈1．5个月（1个月）、移植后1．5个月～〈2．5个月（2个月）、移植后2．5个月～〈3．5个月（3个月）、移植后3．5个月～〈6．5个月（3-6个月）、移植后6．5个月～〈9．5个月（6-9个月）、移植后9．5个月〈12．5个月（9～12个月）]KIR2DLl、KIR3DLl膜蛋白和mRNA的表达水平。结果KIR2DL膜蛋白中位表达水平：非血缘供者移植当天为21．60％，受者在1、2、3、3-6个月时表达水平分别为7．40％、12．00％、16．92％、17．64％；KIR2DLl的mRNA中位表达水平：非血缘供者移植当天为265．14／10。ABL拷贝数，受者移植后1、2、3、3-6、6-9、9-12个月时表达水平分别为332．17、438．31、723．25、414．17、187．60及234．67／10。ABL拷贝数。KIR2DLl的mRNA和膜蛋白表达水平在移植后各个时间点均逐渐升高，且在3个月后达到最高，但mRNA表达水平升高早于膜蛋白。（2）KIR3DLl膜蛋白中位表达水平：非血缘供者移植当天为18．56％，受者在移植后1、2、3、3-6个月时表达水平分别为23．83％、22．57％、23．02％、21．60％；KIR3DLlmRNA中位表达水平：非血缘供者移植当天为572．29／10。ABL拷贝数，受者移植后1、2、3、3-6、6-9、9-12个月时表达水平分别为1233．74、1140．42、876．73、1057．07、739．02、514．43／10。ABL拷贝数。KIR3DLl的mRNA和膜蛋白在移植后1个月的表达水平均已超过了非血缘供者，并在移植后各个时间点均稳定高表达，且mRNA与膜蛋白表达水平同步升高。结论KIR2DLl和KIR3DLl基因移植后的免疫重建规律性不同，为在移植后选择最佳时间点定量检测KIR2DLl、KIR3DLl表达水平提供了实验依据。 目的 在非血缘供者为杀伤细胞免疫球蛋白样受体(KIR)-AA基因型的异基因造血干细胞移植(allo-HSCT)中研究KIR2DL1、KIR3 DLl的免疫重建规律.方法 采用序列特异性引物PCR、流式细胞术和实时荧光定量PCR法,对75对供受者进行KIR基因分型,确定供者均为KIR-AA基因型,并动态检测移植当天及移植后不同时间[移植后0.5个月～＜1.5个月(1个月)、移植后1.5个月～＜2.5个月(2个月)、移植后2.5个月～＜3.5个月(3个月)、移植后3.5个月～＜6.5个月(3～6个月)、移植后6.5个月～＜9.5个月(6～9个月)、移植后9.5个月＜12.5个月(9～12个月)]KIR2DL1、KIR3 DL1膜蛋白和mRNA的表达水平.结果 ①KIR2DL1膜蛋白中位表达水平:非血缘供者移植当天为21.60％,受者在l、2、3、3～6个月时表达水平分别为7.40％、12.00％、16.92％、17.64％;KIR2DL1的mRNA中位表达水平:非血缘供者移植当天为265.14/104 ABL拷贝数,受者移植后l、2、3、3～6、6～9、9～12个月时表达水平分别为332.17、438.31、723.25、414.17、187.60及234.67/104 ABL拷贝数.KIR2DL1的mRNA和膜蛋白表达水平在移植后各个时间点均逐渐升高,且在3个月后达到最高,但mRNA表达水平升高早于膜蛋白.②KIR3DL1膜蛋白中位表达水平:非血缘供者移植当天为18.56％,受者在移植后1、2、3、3～6个月时表达水平分别为23.83％、22.57％、23.02％、21.60％;KIR3DLl mRNA中位表达水平:非血缘供者移植当天为572.29/104 ABL拷贝数,受者移植后1、2、3、3～6、6～9、9～12个月时表达水平分别为1 233.74、1 140.42、876.73、1 057.07、739.02、514.43/104 ABL拷贝数.KIR3 DL1的mRNA和膜蛋白在移植后1个月的表达水平均已超过了非血缘供者,并在移植后各个时间点均稳定高表达,且mRNA与膜蛋白表达水平同步升高.结论 KIR2DLl和KIR3DL1基因移植后的免疫重建规律性不同,为在移植后选择最佳时间点定量检测KIR2DL1、KIR3 DL1表达水平提供了实验依据. |
| Abstract_FL | Objective To investigate the immune reconstruct regularity profile of KIR2DL1 and KIR3DL1 in unrelated-donor allogeneic hematopoietic stem cell transplantation (allo-HSCT) with KIRAA genotype.Method 75 donor-recipient pairs were performed by KIR genotying using PCR-SSP,and all donors were identified with KIR-AA genotype.Dynamic detections (including unrelated-donor on the day of transplantation and the recipient each month post allo-HSCT) of the expression of KIR2DL1/3DL1 on NK cell and mRNA level were performed in 291 cases using flow cytometry (FCM) and real-time fluorescent quantitation PCR (RT-qPCR).Result ①The median expression of KIR2DL1 in unrelateddonor on transplant's day was 21.60％,the median expression of KIR2DL1 in recipient 1 M,2M,3M and 3-6M after transplantation were 7.40％,12.00％,16.92％,17.64％ respectively.The median expression of KIR2DL1 in unrelated-donor on transplant's day was 265.14 copies/10 000abl copies,the median expression of KIR2DL1 in recipient 1M,2M,3M,3-6M,6-9M,9-12M after transplantation were 332.17,438.31,723.25,414.17,180.76 and 234.67 copies/10 000abl copies respectively.The median expression of KIR2DL1 on NK cells and mRNA level gradually increased at all time points after transplantation,and reached the highest expression at 3 months after transplantation.But mRNA expression levels increased earlier than NK cell membrane proteins.②The median expression of KIR3DL1 in unrelated-donors on transplant's day was 18.56％,the median expression of KIR3DL1 in recipient 1M,2M,3M,3-6M after transplantation were 23.83％,22.57％,23.02％,21.60％ respectively.The median expression of KIR3DL1 in unrelated-donor on transplant's day was 572.29 copies/10 000abl copies,the median expression of KIR3DL1 in recipient 1M,2M,3M,3-6M,6-9M,9-12M after transplantation were 1 233.74,1 140.42,876.73,1 057.07,739.02 and 514.43 copies/10 000abl copies respectively.The median expression of KIR3DL1 on NK cells and mRNA level were higher than donors at 1 month after transplantation,and stable expression at all time points after transplantation,so mRNA and NK cell membrane proteins expression increased at the same time.Conclusion The immune reconstruct regularity of KIR2DL1 and KIR3DL1 gene were different,which provided an experimental basis for selecting the best time to detect the expressions of KIR2DL1 and 3DL1 after transplantation. |
| Author | 胡星 何军 张环环 鲍晓晶 王苗 张静 岑建农 吴小津 杨小静 |
| AuthorAffiliation | 苏州大学附属第一医院、江苏省血液研究所、临床检测中心,215006 |
| AuthorAffiliation_xml | – name: 215006 苏州大学附属第一医院、江苏省血液研究所;临床检测中心 |
| Author_FL | Bao Xiaojing Wu Xiaojin Yang Xiaojing Cen Jiannong Hu Xing He Jun Zhang Jing Wang Miao Zhang Huanhuan |
| Author_FL_xml | – sequence: 1 fullname: Hu Xing – sequence: 2 fullname: He Jun – sequence: 3 fullname: Zhang Huanhuan – sequence: 4 fullname: Bao Xiaojing – sequence: 5 fullname: Wang Miao – sequence: 6 fullname: Zhang Jing – sequence: 7 fullname: Cen Jiannong – sequence: 8 fullname: Wu Xiaojin – sequence: 9 fullname: Yang Xiaojing |
| Author_xml | – sequence: 1 fullname: 胡星 何军 张环环 鲍晓晶 王苗 张静 岑建农 吴小津 杨小静 |
| BookMark | eNo9kE1LAkEYx-dgkFZfokN02Wl2dmZn9xj2JglBeAxk3J31hVzLJdJOW2kdwltEJJlBIBFdOkSp-GVy2_VbNGF0ev78nj__5yUBYm7FFQAsqwhqTEcrVpnDEix6ngsRppqCGWYQI5VBZECESAzE__ksSHheSULZJ3GwFwzPgod-0O5O_G706Aefb-HgIjrvhL3B91Nr_PE6ue9IHg5vx6N25De3U7t4La1--adSaVIFzVZ48zK5bAWDftRrBKOr8K4Rdq_D5_d5MOPwfU8s_NU5kNlYzyS3lPTOZiq5mlYsahAlR4jImQa3ieByJ8oMCyNGGLIdUxjCohZH2NGJyoRqI51QU0Oc2qqdY0QzkaXNgaVp7DF3He7ms6XKUdWVA7MnhVq99vsIZMiLpXFxarQKFTd_WJTWg2qxzKv1rM6wachoqv0AZ39-6g |
| ContentType | Journal Article |
| Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| DBID | 2RA 92L CQIGP W91 ~WA 2B. 4A8 92I 93N PSX TCJ |
| DOI | 10.3760/cma.j.issn.0253-2727.2017.08.004 |
| DatabaseName | 维普期刊资源整合服务平台 中文科技期刊数据库-CALIS站点 中文科技期刊数据库-7.0平台 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| DocumentTitleAlternate | Immune reconstruct regularity profile of KIR2DL1 and KIR3DL1 in unrelated-donor allogeneic hematopoietic stem cell transplantation |
| DocumentTitle_FL | Immune reconstruct regularity profile of KIR2DL1 and KIR3DL1 in unrelated-donor allogeneic hematopoietic stem cell transplantation |
| EndPage | 672 |
| ExternalDocumentID | zhxyx201708004 672984595 |
| GrantInformation_xml | – fundername: 国家自然科学基金; 江苏省医学创新团队与领军人才; 江苏省临床医学科技专项; National Natural Science Foundation of China; Jiangsu Province Medical Innovation Team; Clinical Medicine Science and Technology Projects of Jiangsu Province funderid: (81671549、81600142、81072435); (CXTDB2017009); (BL2014038); (81671549,81600142,81072435); (CXTDB2017009); (BL2014038) |
| GroupedDBID | --- -05 2B. 2C~ 2RA 92F 92I 92L ACGFS ALMA_UNASSIGNED_HOLDINGS CCEZO CIEJG CQIGP CW9 F5P OK1 RPM TCJ TGQ U1G U5O W91 ~WA 4A8 93N ABJNI PSX |
| ID | FETCH-LOGICAL-c584-b44eb98ad4ea014578c207470df9e8ec5ca02f6417e1d0645930a5d1db74390c3 |
| ISSN | 0253-2727 |
| IngestDate | Thu May 29 04:00:17 EDT 2025 Wed Feb 14 09:59:09 EST 2024 |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 8 |
| Keywords | 受体,KIR 杀伤细胞,天然 Receptors,KIR Immune reconstitution Killer cells,natural 免疫重建 造血干细胞移植 Hematopoietic stem cell transplantation |
| Language | Chinese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c584-b44eb98ad4ea014578c207470df9e8ec5ca02f6417e1d0645930a5d1db74390c3 |
| Notes | Objective To investigate the immune reconstruct regularity profile of K1R2DL1 and KIR3DL1 in unrelated-donor allogeneic hematopoietic stem cell transplantation （allo-HSCT） with KIR- AA genotype. Method 75 donor-recipient pairs were performed by KIR genotying using PCR-SSP, and all donors were identified with KIR-AA genotype. Dynamic detections （including unrelated-donor on the day of transplantation and the recipient each month post allo-HSCT） of the expression of KIR2DL1/3DL1 on NK cell and mRNA level were performed in 291 cases using flow cytometry （FCM） and real-time fluorescent quantitation PCR （RT-qPCR）. Result （1）The median expression of KIR2DLI in unrelated- donor on transplant＇ s day was 21.60%, the median expression of KIR2DL 1 in recipient 1 M, 2M, 3M and 3- 6M after transplantation were 7.40%, 12.00%, 16.92%, 17.64% respectively. The median expression of KIR2DL1 in unrelated-donor on transplant＇ s day was 265.14 copies/10 000abl copies, the medianexpression of KIR2DL1 in recipient 1M, 2M, 3M, 3-6M, |
| PageCount | 6 |
| ParticipantIDs | wanfang_journals_zhxyx201708004 chongqing_primary_672984595 |
| PublicationCentury | 2000 |
| PublicationDate | 2017 |
| PublicationDateYYYYMMDD | 2017-01-01 |
| PublicationDate_xml | – year: 2017 text: 2017 |
| PublicationDecade | 2010 |
| PublicationTitle | 中华血液学杂志 |
| PublicationTitleAlternate | Chinese Journal of Hematology |
| PublicationTitle_FL | Chinese Journal of Hematology |
| PublicationYear | 2017 |
| Publisher | 215006 苏州大学附属第一医院、江苏省血液研究所 临床检测中心 |
| Publisher_xml | – name: 215006 苏州大学附属第一医院、江苏省血液研究所 – name: 临床检测中心 |
| SSID | ssj0042014 ssib051368330 ssib017477332 ssib001103535 ssib058574913 |
| Score | 2.1212714 |
| Snippet | 目的在非血缘供者为杀伤细胞免疫球蛋白样受体（ⅪR）．AA基因型的异基因造血干细胞移植（allo．HSCT）中研究KIR2DLl、KIR3DLl的免疫重建规律。方法采用序列特异性引物PCR、流... 目的 在非血缘供者为杀伤细胞免疫球蛋白样受体(KIR)-AA基因型的异基因造血干细胞移植(allo-HSCT)中研究KIR2DL1、KIR3 DLl的免疫重建规律.方法 采用序列特异性引物PCR、流式... |
| SourceID | wanfang chongqing |
| SourceType | Aggregation Database Publisher |
| StartPage | 667 |
| SubjectTerms | KIR 免疫重建 受体 天然 杀伤细胞 造血干细胞移植 |
| Title | 异基因造血干细胞移植中非血缘供者KIR2DL1、KIR3DL1免疫重建规律的研究 |
| URI | http://lib.cqvip.com/qk/93752X/201708/672984595.html https://d.wanfangdata.com.cn/periodical/zhxyx201708004 |
| Volume | 38 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAQN databaseName: PubMed Central issn: 0253-2727 databaseCode: RPM dateStart: 20150101 customDbUrl: isFulltext: true dateEnd: 99991231 titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ omitProxy: true ssIdentifier: ssj0042014 providerName: National Library of Medicine |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1Na9RANLQVxIsoKtb60YMDwpKar5nMHJNulvp5kAo9CEuSTVoEt360UHtatdWD9CYiFtsKQhHx4kG0Lf0zNmb7L3xvZrqGIn5dwsubl_e5k3mTnXljGOc9t0Xd3GamnXMLJih5ZorUTkwYnH2IckKtBPcOX7vOxm56lyfoRF__amXV0uxMMpLO_3Jfyf9EFXAQV9wl-w-R7TEFBMAQX7hChOH6VzEmESXhKOEOAqJBwkACIQksEglcxIAAJ4GNMBILEgKxT8KQcIZN3CUiQkwgkREjAWSXdRJ5JIQH68hH1CVNj4-PQgWXNBGKQz4W4fTKpRtO_apNIlfe23DvynsKjZKrTwRICKV2vsRQFIuKc1SBexITER5K4kBifLRDKAAsYNWMuqKpFMGrmjIglhZTJAgYYsAa5bCwQURvFNa-gOeQhIM3a5IzmE4lZ8CGNe3wQDoBJAWNHlBDm0AU2gS04DVXAyGraSquXBWC3Cor5WGhUA4RdsUrSvKobBMWCZV_wLkNaZ1HAlrTVgW80qZ5Vj_qqN2r-q3vUNd0fFUwYW-IcnmlK_LKeMPUWSY6dWHqFKT9oyKue4KfcnonHrkthYz0hODaRl_WsFWHQO-rPQ4MBfeooP3GAcdnHtv3OQxyR5f-zLdhduv7lXp41HYZl6uXVWrkgTRZz21P_EHjgtbv4p-0w9onU9PtyXuQ0ckNdu08bk9WcsHxI8ZhPYkbDlSPPGr0zU8dM24VW4-L1Y1ieW23s9Z92ym-fio3n3afrJTrm9_fLe18-bj7ZgXw5darne3lbmdR95ZvnUe6nxSLS-XLD7vPlorNje76QrH9vHy9UK69KN9_Pm6MN6Lx0TFTn11ippDSm4nnZYngccvLYvzj3uepg0dVWK1cZDxLaRpbTs4828_sFpaMFK4V05bdSvADgZW6J4yB9nQ7O2kMQ86SxDRLGctgbmPFPMvzJGFpbGdZBkPwoDHUc0zzripR0-wFbtA4p13V1C-uB835qbmHc-hanC16p377_JBxCCnVqsvTxsDM_dnsDKThM8lZ-VP4Aengqeg |
| linkProvider | National Library of Medicine |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E5%BC%82%E5%9F%BA%E5%9B%A0%E9%80%A0%E8%A1%80%E5%B9%B2%E7%BB%86%E8%83%9E%E7%A7%BB%E6%A4%8D%E4%B8%AD%E9%9D%9E%E8%A1%80%E7%BC%98%E4%BE%9B%E8%80%85KIR2DL1%E3%80%81KIR3DL1%E5%85%8D%E7%96%AB%E9%87%8D%E5%BB%BA%E8%A7%84%E5%BE%8B%E7%9A%84%E7%A0%94%E7%A9%B6&rft.jtitle=%E4%B8%AD%E5%8D%8E%E8%A1%80%E6%B6%B2%E5%AD%A6%E6%9D%82%E5%BF%97&rft.au=%E8%83%A1%E6%98%9F+%E4%BD%95%E5%86%9B+%E5%BC%A0%E7%8E%AF%E7%8E%AF+%E9%B2%8D%E6%99%93%E6%99%B6+%E7%8E%8B%E8%8B%97+%E5%BC%A0%E9%9D%99+%E5%B2%91%E5%BB%BA%E5%86%9C+%E5%90%B4%E5%B0%8F%E6%B4%A5+%E6%9D%A8%E5%B0%8F%E9%9D%99&rft.date=2017&rft.issn=0253-2727&rft.volume=38&rft.issue=8&rft.spage=667&rft.epage=672&rft_id=info:doi/10.3760%2Fcma.j.issn.0253-2727.2017.08.004&rft.externalDocID=672984595 |
| thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F93752X%2F93752X.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzhxyx%2Fzhxyx.jpg |